Lack of alkaline phosphatase activity predicts meningioma recurrence

Am J Clin Pathol. 2005 Aug;124(2):252-8. doi: 10.1309/482A-WA3U-8DJU-EXWU.

Abstract

Meningiomas usually are benign intracranial tumors. However, some recur despite gross total resection, invade surrounding structures, or, rarely, metastasize. Reduced expression of the nonspecific tissue-type alkaline phosphatase (Pal) has been reported in high-grade meningiomas. To search for a predictor for recurrence, we studied Pal expression by histoenzymology in a series of 54 meningiomas with gross total removal. Pal expression was mostly altered in grades II and III meningiomas (P = .000014) and meningiomas with high MIB-1 values (P = .001). Pal expression correlated with cytogenetic data (P = .000033) and with recurrence (P = .0064); all tumors that recurred had abnormal Pal expression (13/13). In univariate analysis, Pal expression was the only variable correlated with recurrence-free survival (P = .035). Histochemical detection of Pal is a useful, easy, and low-cost technique to predict recurrence in meningiomas.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alkaline Phosphatase / biosynthesis*
  • Biomarkers, Tumor / analysis*
  • Chromosome Aberrations
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Meningeal Neoplasms / enzymology*
  • Meningeal Neoplasms / genetics
  • Meningeal Neoplasms / pathology
  • Meningioma / enzymology*
  • Meningioma / genetics
  • Meningioma / pathology
  • Middle Aged
  • Neoplasm Recurrence, Local / enzymology*
  • Neoplasm Recurrence, Local / pathology
  • Prognosis

Substances

  • Biomarkers, Tumor
  • Alkaline Phosphatase